Bide Pharmaceuticals released its first-quarter performance, with a net profit attributable to the parent company of 30.69 million yuan, a year-on-year increase of 17.71%
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, Bide Pharmaceuticals disclosed its first-quarter report for 2025, reporting revenue of 296 million yuan, a year-on-year increase of 12.83%; net profit attributable to the parent company of 30.69 million yuan, a year-on-year increase of 17.71%; and net profit excluding non-recurring items of 28.08 million yuan, a year-on-year increase of 10.40%. Basic earnings per share were 0.34 yuan
According to the Zhitong Finance APP, Bide (688073.SH) disclosed its first-quarter report for 2025, showing that the company achieved revenue of 296 million yuan during the reporting period, a year-on-year increase of 12.83%; net profit attributable to the parent company was 30.69 million yuan, a year-on-year increase of 17.71%; and net profit excluding non-recurring items was 28.08 million yuan, a year-on-year increase of 10.40%. The basic earnings per share were 0.34 yuan